Supply@ME Capital PLC New equity funding secured for £1,552,500

RNS Number : 4474O

Supply@ME Capital PLC

15 May 2024

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION 2014/596/EU, WHICH IS PART OF UNITED KINGDOM DOMESTIC LAW PURSUANT TO THE MARKET ABUSE (AMENDMENT) (EU EXIT) REGULATIONS (SI 2019/310) ("UK MAR"). UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION (AS DEFINED IN UK MAR) IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

15 May 2024

 

Supply@ME Capital plc

(the "Company", "Supply@ME" or "SYME" and, together with its subsidiaries, the "Group")

New equity funding secured for £1,552,500

SYME, the fintech business which provides an innovative fintech platform (the "Platform") for use by manufacturing and trading companies to access Inventory Monetisation© ("IM") solutions enabling their businesses to generate cashflow, is pleased to announce that it has secured new equity funding with gross proceeds of £1,552,500 (the "New Equity Funding").

The New Equity Funding comprises:

·   The entry into a binding subscription agreement with a UK investment firm for £1,552,500 of gross proceeds on behalf of its private clients (the "Subscription").

·    The issue of 9,000,000,000 new ordinary shares of £0.00002 each (the "Subscription Shares") at a price of 0.01725 pence per Subscription Shares to raise gross proceeds of £1,552,500.

·    Application will be made to the Financial Conduct Authority and to the London Stock Exchange for the Subscription Shares to be admitted to the standard segment of the Official List and to trading on the London Stock Exchange's main market for listed securities, respectively (the "Admission").

·    The Admission is expected to occur at 8.00am on or around 28 May 2024.

·   Following the issue of the Subscription Shares, the Company will issue 450,000,000 new warrants to the UK investment firm, the exercise price of the warrants is 0.01725 pence each, with the warrants being exercisable anytime up to 28 May 2029.

·    Keith, Bayley, Rogers & Co. Limited acted as corporate broker to SYME in relation to the Subscription.

As previously announced on 1 May 2024 in connection with the Annual Report and Accounts for the year ended 31 December 2023 ("2023 Annual Report and Accounts"), the Company has been exploring alternative options for funding to allow it to meet its ongoing commitments and obligations. This New Equity Funding provides the Company with additional funding to that available under the Top-Up Shareholder Loan Agreement that was executed with The AvantGarde Group S.p.A ("TAG") on 28 September 2023, further details of which can be found in the 2023 Annual Report and Accounts.

 

The New Equity Funding is expected to be used by the Company and Group to satisfy its ongoing working capital requirements and to improve the Company's overall capitalisation as SYME seeks to deploy an increasing number of IM transactions, including, inter alia, from i) the IM programme with the Italian neo banking group announced by the Company on 29 April 2024; ii) the commitment achieved from an asset manager specialised in digital assets to subscribe the first tranche of on over-all security token issuance as announced by the Company on 5 April 2024; and iii) the Group's first White-Label IM agreement with Banco BPM S.p.A announced by the Company on 3 January 2024.

 

Alessandro Zamboni, CEO of SYME, said:

"I am excited to see such great interest on our company by Keith, Bayley, Rogers & Co. Limited and its investors. It is the first time that SYME engaged a broker to raise capital and it has demonstrated that, as recorded in 2023, London remains Europe's most active equity market with more capital raised than the other European exchanges for high-growth businesses.

I am sure that our inventory funders and partners will see this capital infusion as a positive step forward for SYME, considering its key role as inventory specialist within the current Inventory Monetisation programmes and future opportunities."

Admission of new ordinary shares and Total Voting Rights

 

The Admission is expected to occur at 8.00am on or around 28 May 2024. The Subscription is conditional on Admission.  

Following Admission, the Company's issued ordinary share capital will comprise 71,732,142,145 ordinary shares of £0.00002 each (assuming no other warrant conversions take place between now and 28 May 2024). Accordingly, this number will represent the total voting rights in the Company, and, following admission of the Subscription Shares, may be used by shareholders as the denominator for the calculation by which they can determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure and Transparency Rules. The new shares will rank pari passu in all respects with the ordinary shares of the Company currently traded on London Stock Exchange's main market for listed securities.

 

For the purposes of UK MAR, the person responsible for arranging release of this announcement on behalf of SYME is Alessandro Zamboni, CEO.

Contact information

Alessandro Zamboni, CEO, Supply@ME Capital plc, [e-mail]

Notes

SYME and its operating subsidiaries provide its Platform for use by manufacturing and trading companies to access inventory trade solutions enabling their businesses to generate cashflow, via a non-credit approach and without incurring debt.  This is achieved by their existing eligible inventory being added to the Platform and then monetised via purchase by third party Inventory Funders.  The inventory to be monetised can include warehoused goods waiting to be sold to end-customers or goods that are part of a typical import/export transaction.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

IOEGPURAAUPCPGC